openPR Logo
Press release

A Deep Dive into Chronic Pancreatitis (CP) Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

03-25-2025 08:08 AM CET | Health & Medicine

Press release from: The Business Research Company

Chronic Pancreatitis (CP)

Chronic Pancreatitis (CP)

Which drivers are expected to have the greatest impact on the over the chronic pancreatitis (cp) market's growth?
The increasing consumption of alcohol is also driving the growth of the chronic pancreatitis market. Chronic pancreatitis, often linked to long-term excessive alcohol consumption, leads to inflammation and damage to the pancreas, causing fibrosis and dysfunction. The rise in alcohol consumption, particularly among younger populations, is a major factor contributing to this increase. According to Kirin Holdings Company, global beer consumption rose by 2.9% in 2022, which reflects the broader trend of increasing alcohol consumption worldwide. As alcohol consumption rises, the chronic pancreatitis market will continue to expand, driven by the need for treatments to manage the condition and its complications.

Get Your Chronic Pancreatitis (CP) Market Report Here:
https://www.thebusinessresearchcompany.com/report/chronic-pancreatitis-cp-global-market-report

What is the future CAGR of the chronic pancreatitis (cp) market, and how will it impact industry expansion?
The market size for chronic pancreatitis (CP) has experienced significant growth in recent years. It is projected to expand from $4.91 billion in 2024 to $5.25 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this historical growth include increased alcohol consumption, higher smoking rates, genetic predisposition and family history, greater awareness of pancreatic diseases, a rise in diabetes cases linked to pancreatitis, increased healthcare expenditures, and improved accessibility to healthcare services.

The chronic pancreatitis (CP) market is forecasted to witness substantial growth, reaching $6.72 billion in 2029 with a CAGR of 6.4%. Factors fueling this expansion include an aging population, increasing demand for enzyme replacement therapies, rising awareness of early diagnosis, improvements in healthcare infrastructure across emerging markets, novel pain management therapies, and ongoing research and clinical trials for pancreatitis treatments. Significant trends in this period include the integration of artificial intelligence in diagnostic imaging, adoption of minimally invasive surgical techniques, wearable devices for continuous health monitoring, next-generation sequencing for genetic analysis, machine learning applications in disease progression tracking, and the development of advanced diagnostic tools.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21146&type=smp

What are the most significant trends transforming the chronic pancreatitis (cp) market today?
In the chronic pancreatitis market, companies are focusing on technological advancements such as enzyme replacement therapy to treat exocrine pancreatic insufficiency (EPI) in chronic pancreatitis patients. Enzyme replacement therapy involves taking oral pancreatic enzymes to aid digestion in patients with insufficient pancreatic function. For instance, in July 2023, First Wave BioPharma Inc., a US-based biopharmaceutical company, announced results from the Phase 2 SPAN clinical trial evaluating an enhanced enteric microgranule formulation of adrulipase for treating EPI in patients with cystic fibrosis (CF) and chronic pancreatitis. Adrulipase is a recombinant lipase enzyme derived from Yarrowia lipolytica yeast, administered as an oral, non-systemic biologic capsule, designed to break down fat molecules in the digestive tract so that they can be absorbed as nutrients by EPI patients.

Which key market segments comprise the chronic pancreatitis (cp) market and drive its revenue growth?
The chronic pancreatitis (CP) market covered in this report is segmented -

1) By Treatment: Analgesic, Artificial Digestive Enzyme, Protein Supplements, Steroids, Antibiotics, Other Treatments
2) By Diagnosis: Computed Tomography (CT) Scan, Magnetic Resonance Cholangiopancreatography, Ultrasound Sonography, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral
4) By End User: Hospitals, Homecare, Other End Users

Subsegments:
1) By Analgesic: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids
2) By Artificial Digestive Enzyme: Pancrelipase, Pancreatin
3) By Protein Supplements: Branched-Chain Amino Acids (BCAA), Whey Protein
4) By Steroids: Prednisone, Dexamethasone
5) By Antibiotics: Ciprofloxacin, Metronidazole
6) By Other Treatments: Endoscopic Treatment, Surgery

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21146

What regions are at the forefront of chronic pancreatitis (cp) market expansion?
North America was the largest region in the chronic pancreatitis (CP) market in 2024. The regions covered in the chronic pancreatitis (cp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the chronic pancreatitis (cp) market?
Major companies operating in the chronic pancreatitis (CP) market are Pfizer, Johnson & Johnson, Merck & Co Inc, AbbVie Inc, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Baxter, CSL Behring, Octapharma AG, Dr. Reddy's Laboratories, Nestle Health Science, Cerata Pharmaceuticals, Unichem Laboratories Ltd, LGM Pharma, Aptalis Pharmaceutical Technologies, Digestive Care Inc, Akron Biotech

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21146&type=smp

What Is Covered In The Chronic Pancreatitis (CP) Global Market Report?

•Market Size Forecast: Examine the chronic pancreatitis (cp) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the chronic pancreatitis (cp) market for a structured understanding.
•Key Players Overview: Analyze major players in the chronic pancreatitis (cp) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the chronic pancreatitis (cp) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the chronic pancreatitis (cp) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the chronic pancreatitis (cp) market.
•Industry Challenges: Identify potential risks and obstacles affecting the chronic pancreatitis (cp) market.
•Competitive Landscape: Review strategic developments in the chronic pancreatitis (cp) market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A Deep Dive into Chronic Pancreatitis (CP) Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034 here

News-ID: 3935229 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Chronic

Chronic Pain Treatment Market - Relieving Chronic Pain: Discover the Latest Inno …
Newark, New Castle, USA: The "Chronic Pain Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Chronic Pain Treatment Market: https://www.growthplusreports.com/report/chronic-pain-treatment-market/8030 This latest report researches the industry structure,
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991 This latest report researches the
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Chronic Hepatitis Therapeutics Market - Empowering Liver Health, Defying Chronic …
Newark, New Castle, USA - new report, titled Chronic Hepatitis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Hepatitis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Hepatitis Therapeutics market. The report offers an overview of
Chronic Phase Chronic Myeloid Leukemia Market to Witness Growth by 2032, Estimat …
DelveInsight's "Chronic Phase Chronic Myeloid Leukemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Phase Chronic Myeloid Leukemia , historical and forecasted epidemiology as well as the Chronic Phase Chronic Myeloid Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic Phase Chronic Myeloid Leukemia market report provides current treatment practices, emerging drugs, the market share
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them